Trial intelligence / Profile preview

Liposomal Bupivacaine vs Dexamethasone in Supraclavicular Brachial Plexus Block for Distal Radial Fracture Surgery

NCT07665762Phase 3Recruiting

Sponsor
The University of Hong Kong
Start
Aug 2026
Primary completion
Sep 2028
Countries
1
01

Overview

Phase 3, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Weighted area under curve pain score with movement at 48 hours. Started Aug 2026; status: recruiting.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07665762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07665762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call